Cargando…

Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults

INTRODUCTION: Type 1 diabetes is characterized by pancreatic islet inflammation and autoimmune-driven pancreatic β-cell destruction. Interferon-α (IFNα) is a key player in early human type 1 diabetes pathogenesis. IFNα activates the tyrosine kinase 2 (TYK2)-signal transducer and activator of transcr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dos Santos, Reinaldo S., Guzman-Llorens, Daniel, Perez-Serna, Atenea A., Nadal, Angel, Marroqui, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579912/ https://www.ncbi.nlm.nih.gov/pubmed/37854597 http://dx.doi.org/10.3389/fimmu.2023.1263926

Ejemplares similares

BCL-XL Overexpression Protects Pancreatic β-Cells against Cytokine- and Palmitate-Induced Apoptosis
por: Perez-Serna, Atenea A., et al.
Publicado: (2023)

Temporal regulation of interferon signalling in human EndoC-βH1 cells
por: Dhayal, Shalinee, et al.
Publicado: (2022)

Characterization of the Secretome, Transcriptome, and Proteome of Human β Cell Line EndoC-βH1
por: Ryaboshapkina, Maria, et al.
Publicado: (2022)

Characterization of Stimulus-Secretion Coupling in the Human Pancreatic EndoC-βH1 Beta Cell Line
por: Andersson, Lotta E., et al.
Publicado: (2015)

Glucocorticoid-mediated induction of ZBTB16 affects insulin secretion in human islets and EndoC-βH1 β-cells
por: Karagiannopoulos, Alexandros, et al.
Publicado: (2023)

Toxicity of fatty acid profiles of popular edible oils in human EndoC-βH1 beta-cells
por: von Hanstein, Anna-Sophie, et al.
Publicado: (2020)

Changes to the identity of EndoC-βH1 beta cells may be mediated by stress-induced depletion of HNRNPD
por: Jeffery, Nicola, et al.
Publicado: (2021)

Characterization of the functional and transcriptomic effects of pro-inflammatory cytokines on human EndoC-βH5 beta cells
por: Frørup, Caroline, et al.
Publicado: (2023)

Dynamics of Insulin Secretion from EndoC-βH1 β-Cell Pseudoislets in Response to Glucose and Other Nutrient and Nonnutrient Secretagogues
por: Teraoku, Hiroki, et al.
Publicado: (2017)

Electrophysiological properties of human beta-cell lines EndoC-βH1 and -βH2 conform with human beta-cells
por: Hastoy, Benoît, et al.
Publicado: (2018)

Extracellular Vesicles Released by Enterovirus-Infected EndoC-βH1 Cells Mediate Non-Lytic Viral Spread
por: Netanyah, Eitan, et al.
Publicado: (2020)

EndoC-βH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion
por: Blanchi, Bruno, et al.
Publicado: (2023)

Deucravacitinib: First Approval
por: Hoy, Sheridan M.
Publicado: (2022)

Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells
por: Krizhanovskii, Camilla, et al.
Publicado: (2017)

The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates
por: Tsonkova, Violeta Georgieva, et al.
Publicado: (2017)

A CRISPR/Cas9 genome editing pipeline in the EndoC-βH1 cell line to study genes implicated in beta cell function
por: Grotz, Antje K., et al.
Publicado: (2020)

In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model
por: Dos Santos, Reinaldo Sousa, et al.
Publicado: (2022)

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
por: Jing, Shan, et al.
Publicado: (2023)

Deucravacitinib for the Treatment of Psoriatic Disease
por: Lé, Ana Maria, et al.
Publicado: (2022)

Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects
por: Chimalakonda, Anjaneya, et al.
Publicado: (2022)

Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods
por: Dos Santos, Reinaldo Sousa, et al.
Publicado: (2022)

A Toolbox for Translational Research on Beta Cell Function: Commentary on: “A Dual Reporter EndoC-βH1 Human Beta Cell Line for Efficient Quantification of Calcium Flux and Insulin Secretion.”
por: Schulze, Torben, et al.
Publicado: (2020)

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors
por: Chimalakonda, Anjaneya, et al.
Publicado: (2021)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
por: Catlett, Ian M., et al.
Publicado: (2022)

Deucravacitinib for the treatment of psoriatic arthritis: the evidence so far
por: Martins, Ana, et al.
Publicado: (2023)

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
por: Jin, Joy Q, et al.
Publicado: (2023)

Successful treatment of refractory subacute cutaneous lupus erythematosus with deucravacitinib
por: Bouché, Nicole, et al.
Publicado: (2023)

What is the point of pseudokinases?
por: Raju, Saravanan, et al.
Publicado: (2015)

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
por: Potestio, Luca, et al.
Publicado: (2023)

Pseudokinase is active after all
por: LeBrasseur, Nicole
Publicado: (2008)

Nucleotide-binding mechanisms in pseudokinases
por: Hammarén, Henrik M., et al.
Publicado: (2016)

Tribbles Pseudokinases in Colorectal Cancer
por: Ferreira, Bibiana I., et al.
Publicado: (2021)

Pseudokinases, Tribbles Proteins and Cancer
por: Velasco, Guillermo, et al.
Publicado: (2023)

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial
por: Morand, Eric, et al.
Publicado: (2022)

The efficacy and safety of tyrosine kinase 2 inhibitor deucravacitinib in the treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
por: Qiu, Jingyue, et al.
Publicado: (2023)

Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression
por: Wang, Wen-Ling, et al.
Publicado: (2020)

Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
por: Oliel, Sarah, et al.
Publicado: (2023)

Purification, Characterization, and Gene Expression of Rice Endo-β-N-Acetylglucosaminidase, Endo-Os
por: Maeda, Megumi, et al.
Publicado: (2021)

Stress-induced pseudokinase TRB3 augments IL1β signaling by interacting with Flightless homolog 1
por: Gonuguntla, Sumati, et al.
Publicado: (2023)

SCYL pseudokinases in neuronal function and survival
por: Pelletier, Stephane
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5dudfv1m31j8icvjo6lk2hhqvn